Psychedelic Medicine: The Next Frontier in Mental Health
A new frontier in treating mental health conditions, psychedelic therapy has brought about lasting change for patients and people around the world. Field Trip Health has been facilitating psychedelic-assisted therapy since March 2020 in our Health Centres across North America – and we’re pleased to publish a whitepaper report outlining the importance of this medicine and preliminary results from the protocol.
Dr. Michael Verbora, MBA MD (Field Trip Medical Director, Toronto) and Dr. Ben Medrano, MD (Field Trip Medical Director, New York) will discuss the paper, present the researched-based evidence of the efficacy of psychedelic therapies, and outline the ongoing clinical work that Field Trip Health is facilitating, using ketamine-assisted therapy to treat treatment-resistant mental health conditions with lasting success. This session will deliver useful & thought-provoking information catered to care providers who wish to learn more about the resurgence of psychedelic medicine.
This webinar will:
- Educate and raise awareness regarding the current options in ketamine-assisted psychotherapy
- Destigmatize the use of psychedelic drugs to treat treatment-resistant mental health conditions
- Create an open forum for the comprehensive white paper report that Field Trip Health has published